Making HT-1 Treatment Simpler

NITYR is therapeutically equivalent1 to Orfadin*

Why Choose NITYR for Your Patients?

  • NITYR (nitisinone) tablets are therapeutically equivalent to Orfadin (nitisinone) capsules
  • Offers additional benefits and may be more convenient
  • Comes with a $0 co-pay for eligible commercially insured patients2
  • Your patients can experience NITYR with the Three-Week Free Trial3 without interruption of the delivery of Orfadin. They can switch back at any point during the trial.
Find out more about NITYR About the Free Trial

The Tablet For All Life Stages

NITYR is suitable for HT-1 patients of all ages. The tablets are very small4 (baby aspirin sized) and tasteless. Patients from the age of three onwards are usually able to swallow very small tablets. For infants, NITYR can be mixed with applesauce or a suspension can be created.

NITYR tablets NITYR as a suspension

NITYR Three-Week Free Trial

The NITYR Free Trial offer gives patients an opportunity to try NITYR before making the decision to move from their current nitisinone. Patients can receive NITYR free of charge for three-weeks without interrupting their regular Orfadin prescription.

NITYR Free Trial Offer

1 Data on file NIT/02/17 2 $0 co-pay for eligible commercially insured patients (up to $15,000 per year per patient) 3 Free trial offer: Subject to terms and conditions and eligibility criteria. Patients can try NITYR for three weeks for free as long as their doctor prescribes it. Subject to terms and conditions, eligibility criteria, and to other federal and state law. 4 Data on file NIT/03/18 *Orfadin is a registered trademark licensed by Sobi, Inc. or its affiliates.